SEOUL, Feb. 23 (Korea Bizwire) — A South Korean panel of experts said Tuesday that vaccines for the novel coronavirus by U.S. pharmaceutical company Pfizer Inc. showed a more than 95 percent efficacy rate, and the use of the vaccine is not problematic for young people. The advisory board consisting of outside experts announced its [...]
SEOUL, Feb. 23 (Korea Bizwire) — South Korea will begin its first inoculations against the novel coronavirus later this week, health authorities said Tuesday, adding it might not be able to achieve herd immunity by November. The Korea Disease Control and Prevention Agency (KDCA) said it will launch the free inoculation program with British-Swedish pharmaceutical [...]
SEOUL, Feb. 22 (Korea Bizwire) — South Korea could produce locally developed vaccines against the novel coronavirus early next year, the ICT minister said Monday, as the country seeks to prepare for a drawn-out fight against the pandemic. Minister of Science and ICT Choi Ki-young said the government will continue to support development of local [...]
SEOUL, Feb. 22 (Korea Bizwire) — Less than half of South Koreans are willing to receive COVID-19 vaccine shots immediately, without waiting for further reports on those vaccines’ effects, an opinion poll showed Monday. In the survey conducted on 1,020 people aged 18 or over by the Korea Society Opinion Institute from last Friday to [...]
SEOUL, Feb. 21 (Korea Bizwire) — South Korea will begin administering 117,000 doses of Pfizer vaccines to medical staff on Saturday as the vaccines are expected to arrive in the country later this week, Prime Minister Chung Sye-kyun said Sunday. “On Feb. 26, 117,000 doses of Pfizer vaccines will arrive in the country and the [...]
SEOUL, Feb. 20 (Korea Bizwire) — South Korean biopharmaceutical company Celltrion Inc. will supply its antibody treatment for COVID-19 without a profit margin in South Korea, its chairman has said. Celltrion’s CT-P59 won the South Korean drug safety agency’s conditional approval earlier this month, becoming the first locally made treatment for the virus. The drug [...]
SEOUL, Feb. 18 (Korea Bizwire) – Celltrion Inc. said Thursday that its anti-COVID-19 monoclonal antibody treatment has confirmed neutralizing potency against the British variant, and the South Korean pharmaceutical giant has also begun developing a neutralizing antibody cocktail treatment. CT-P59, an anti-COVID-19 monoclonal antibody treatment, won the country’s drug safety agency’s conditional approval earlier this [...]
SEOUL, Feb. 18 (Korea Bizwire) — The risk of breast and colon cancer increases after menopause if weight exceeds an optimal level, research showed Wednesday. Researchers from Samsung Medical Center had arrived at this conclusion following an analysis of the correlation between obesity and breast or colon cancer for about 600 women who participated in [...]
SEOUL, Feb. 17 (Korea Bizwire) — A South Korean research team has developed an artificial intelligence (AI) program that studies the distinct features of patients undergoing joint replacement surgery to predict the risks of side effects. Researchers from Seoul National University Hospital announced Tuesday that they had developed an AI-based web platform that can predict [...]
SEOUL, Feb. 17 (Korea Bizwire) — South Korean pharmaceutical giant Celltrion Inc. began supplying its COVID-19 antibody treatment to medical institutions in the country Wednesday. CT-P59 won the drug safety agency’s conditional approval earlier this month, becoming the first locally made treatment for COVID-19. CT-P59 will be administered to COVID-19 patients at higher risk, referring [...]